GORE MEDICAL RECEIVES BREAKTHROUGH DEVICE DESIGNATION FOR THE GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS
CAUTION: Investigational device. Limited by United States law to investigational use.
Apr 12, 2022
Gore Announces First Commercial In-Human Use of GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System for TEVAR in Australia
New delivery system provides controlled and predictable placement of Gore’s highly conformable and time-tested stent graft
FDA Approves GORE® CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke
Gore REDUCE Clinical Study demonstrated 77 percent relative reduction in recurrent ischemic stroke when PFO closure was combined with antiplatelet therapy, compared to antiplatelet therapy alone
Gore to Highlight Real-World Aortic Data at 45th Annual VEITHsymposium<sup>®</sup>
Company shares findings from the Global Registry for Endovascular Aortic Treatment (GREAT), the largest industry-sponsored registry of aortic stent grafts
Gore Announces Successful Patient Implant of Endovascular Stent Graft for the Ascending Aorta
GORE® Ascending Stent Graft, an investigational device, is an off-the-shelf endovascular solution designed to treat life-threatening Type A dissections of the ascending aorta
Gore Acquires Pipeline Medical Technologies, Inc.
Acquisition of transcatheter mitral chordal repair technology builds on Gore’s structural heart capabilities
First Patient in Europe Receives Implant of GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System and Enrolls in Post-Market Registry
Investigator initiated EXCeL Registry will assess safety and abdominal aortic aneurysm treatment success in patients with challenging anatomies